Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Optic Nerve Pit-associated Macular Detachment with Pars Plana Vitrectomy Combined with Multilayered ILM Optic Pit Plug and Heavy Silicone Oil.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Observation of Corneal Nerve Regeneration after Oxervate Treatment with Confocal Microscopy - A Clinical Case.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Between Scylla and Charybdis?-Health insurance claims-data to monitor quality of service delivery in ophthalmology.

Eye (London, England)·2024
Same author

Protracted Intralenticular Implant of Sustained-Release Dexamethasone Implant (Ozurdex).

Klinische Monatsblatter fur Augenheilkunde·2024
Same author

Silicone Oil Tamponade for Therapy of Primary Retinal Detachment in Patients Who Live at High Altitudes.

Klinische Monatsblatter fur Augenheilkunde·2024
Same author

Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature.

Klinische Monatsblatter fur Augenheilkunde·2024
Same journal

Erratum.

Developments in ophthalmology·2021
Same journal

Pediatric Vitreoretinal Surgery and Integrated Intraoperative Optical Coherence Tomography.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography for Pediatric Lamellar Corneal Transplant Surgery.

Developments in ophthalmology·2021
Same journal

The Use of Optical Coherence Tomography as an Intraoperative Adjunct of Oculoplastic Surgery.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography in Strabismus Surgery.

Developments in ophthalmology·2021
Same journal

Use of Integrated Intraoperative Ocular Coherence Tomography in Pediatric Cataract Surgery: Thinking outside the Box.

Developments in ophthalmology·2021
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Macular edema--rationale for therapy.

Thomas J Wolfensberger, Zdenek J Gregor

    Developments in Ophthalmology
    |August 13, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Macular edema results from blood-retinal barrier breakdown, driven by growth factors and pressure changes. Treatments target these mechanisms using medications or surgery to restore barrier integrity and reduce fluid buildup.

    Related Experiment Videos

    Last Updated: Jun 10, 2026

    Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
    10:24

    Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

    Published on: February 12, 2018

    Area of Science:

    • Ophthalmology
    • Cell Biology
    • Physiology

    Background:

    • Macular edema involves blood-retinal barrier (BRB) breakdown, influenced by growth factors affecting tight junctions.
    • Pathophysiology includes increased hydrostatic pressure and decreased osmotic pressure gradients, leading to fluid accumulation.
    • Understanding these mechanisms is crucial for developing effective treatments for macular edema.

    Purpose of the Study:

    • To review the pathophysiological mechanisms underlying macular edema.
    • To discuss the therapeutic strategies targeting BRB integrity and fluid dynamics.
    • To explain the rationale behind medical and surgical interventions for macular edema.

    Main Methods:

    • Review of existing literature on macular edema pathophysiology and treatment.
    • Analysis of the mechanisms of action for various pharmacological agents (NSAIDs, corticosteroids, carbonic anhydrase inhibitors, anti-VEGF agents).
    • Evaluation of surgical interventions like vitrectomy and their proposed effects on macular edema.

    Main Results:

    • Medical treatments modulate inflammatory pathways, growth factors (VEGF), and tight junction proteins (occludin).
    • Corticosteroids and anti-VEGF agents strengthen the BRB by downregulating VEGF and restoring occludin.
    • Vitrectomy alleviates traction, reduces hydrostatic pressure, and may improve oxygen transport and growth factor clearance.

    Conclusions:

    • Therapeutic interventions for macular edema aim to inhibit specific pathophysiological mechanisms.
    • Both medical and surgical approaches effectively target BRB integrity, fluid transport, and underlying disease processes.
    • A comprehensive understanding of these mechanisms guides clinical treatment decisions for macular edema.